Product NewsUS Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsSigma-Aldrich Launches ChemBlogs: An Industry-First Web Tool for Open Scientific Discussion
Product NewsOXFORD BIOMEDICA RECEIVES NOTICE OF ALLOWANCE FOR KEY US PATENT COVERING PARKINSON’S DISEASE PRODUCT, PROSAVIN®
